Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

Women who want longer lashes now have an alternative to messy mascara. Latisse, a version of a drug developed for glaucoma, was recently approved by the U.S. Food and Drug Administration to promote eyelash growth. Latisse is dabbed along the base of the eyelashes and must be applied daily, or its lash-­thickening effect will wear off. Available only by prescription, it has some potential side effects, including eye redness, itchy eyes, and discoloration of the eyelid.

Product: Latisse
Cost: $120 for a 30-day supply
Source: www.latisse.com
Company: Allergan

Credit: Courtesy of Allergan

Tagged: Biomedicine

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me